Candidate gene
Marker
| may be a novel diagnostic marker for colorectal cancer |
|
might be a potential indicator for the clinical assessment of gastric cancer prognosis |
|
presence of RNF43 mutations could be used as a predictive biomarker for patient selection supporting the clinical development of Wnt inhibitors in subtypes of cancer |
|
RNF43 is a possible biomarker for therapy selection in gastric cancer |
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | | | |
harnessing phospho-regulation of RNF43 might be a potential therapeutic strategy for tumours with RNF43 mutations |
| |